An imaging analysis of 99mTc-UBI (29-41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 6, 2008, Pages 1056-1064

  Akhtar, Muhammad Saeed ^a,b   Khan, Muhammad Ejaz ^a   Khan, Bashar ^c   Irfanullah, Javaid ^a   Afzal, Muhammad Shahzad ^a   Khan, Muhammad Aleem ^a   Nadeem, Muhammad Afzal ^a   Jehangir, Mustansar ^c   Imran, Muhammad Babar ^a  

^a PUNJAB MEDICAL COLLEGE   (Pakistan)

^b PAKISTAN INSTITUTE OF ENGINEERING AND APPLIED SCIENCES   (Pakistan)

^c PAKISTAN INSTITUTE OF NUCLEAR SCIENCE AND TECHNOLOGY   (Pakistan)

Author keywords

Ciprofloxacin; Infection detection; Monitoring therapy; Synthetic peptide; Technetium; Ubiquicidin

Indexed keywords

AGAR; ANTIBIOTIC AGENT; CIPROFLOXACIN; PEPTIDE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; UBIQUICIDIN PEPTIDE 29-41 TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CIRCULATION; COLONY FORMING UNIT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE PREDISPOSITION; IMAGE ANALYSIS; NONHUMAN; PROTEIN LOCALIZATION; RABBIT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THIGH; TREATMENT DURATION;

ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; METABOLIC CLEARANCE RATE; MYOSITIS; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; PEPTIDE FRAGMENTS; RABBITS; RADIOPHARMACEUTICALS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; THIGH; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 43749106636     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0671-3     Document Type: Article

References (21)

1. Becker W, Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis. 2001;1:326-33.
2. Love C, Palestro CJ. Radionuclide imaging of infection. J Nucl Med Technol. 2004;32:47-57.
3. 99m Tc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med. 2006;47:1908-13.
4. 111 In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med. 2006;47:587-94.
5. 18 F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med. 2006;47:625-32.
6. st century. Braz Arch Biol Technol. 2002;45:25-37.
7. Fournier B, Zhao X, Lu T, Drlica K, Hooper DC. Selective targeting of topoisomerase IV and DNA gyrase in Stphylococcus aureus: different patterns of quinolone-induced inhibition of DNA Synthesis. Antimicrob Agents Chemother. 2000;44:2160-5.
8. 99m ciprofloxacin (Infection) in suspected orthopaedic infection: a comparison with sequential bone/gallium imaging. Eur J Nucl Med. 2001;28:822-30.
9. 99m Tc-HMPAO leukocyte scintigraphy. J Nucl Med. 2001;42:567-74.
10. 99m Tc-ciproflaxacin (infection) imaging in the diagnosis of knee prosthesis infections. Nucl Med Commun. 2002;23:167-70.
11. 99m Tc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med. 2003;44:920-6.
12. Appelboom T, Emery P, Tant L, Dumarey N, Schoutens A. Evaluation of technetium-99m-ciprofloxacin (infection) for detecting sites of inflammation in arthritis. Rheumatology. 2003;42:1179-82.
13. Jones ME, Boenink NM, Verhoef J, Kohrer K, Schmitz FJ. Multiple mutations conferring ciprofloxacin resistance in staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment. J Antimicrob Chemother. 2000;45:353-6.
14. 99m Tc-labeled antimicrobial peptide ubiquicidin (29-41) accumulations less in Escherichia coli infection than in Staphylococcus aureus infection. J Nucl Med. 2004;45:849-56.
15. Lupetti A, Welling MM, Pauwels EKJ, Niberring PH. Radiolabeled antimicrobial peptides for infection detection. Lancet Infect Dis. 2003;3:223-9.
16. 99m Tc-labeled antimicrobial peptides [abstract]. Nucl Med Commun. 2000;21:575-6.
17. 99m Tc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med. 2005;46:567-73.
18. 99m Tc-labeled UBI 29-41 peptide for monitoring the efficacy of antimicrobial agents in mice infected with staphylococcus aureus. J Nucl Med. 2004;45:321-6.
19. Hugo WB, Russel AD, Hodges NA, Danyer S, et al. Laboratory evaluation of antimicrobial agents. Huge and Russel's pharmaceutical microbiology. 7th ed. Oxford: Blackwell; 2004. p. 199-201.
20. Duncan DB. Multiple range and multiple F test. Biometrics. 1995;11:1-42.
21. 99m Tc-UBI specificity for bacteria. Nucl Med Biol. 2003;30:605-15.